A detailed history of Affinity Asset Advisors, LLC transactions in Insmed Inc stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 50,000 shares of INSM stock, worth $3.67 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
50,000
Previous 125,000 60.0%
Holding current value
$3.67 Million
Previous $8.38 Million 56.42%
% of portfolio
0.63%
Previous 1.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$62.0 - $79.01 $4.65 Million - $5.93 Million
-75,000 Reduced 60.0%
50,000 $3.65 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $2.75 Million - $8.71 Million
125,000 New
125,000 $8.38 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.94B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.